Results 171 to 180 of about 3,079 (276)

Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell Tumours

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Following promising results in a phase II trial evaluating GAMMA as salvage therapy for relapsed germ cell tumours (GCT) who had progressed on cisplatin‐based chemotherapy, the GAMMA regimen was adopted into clinical practice at St Bartholomew's Hospital.
Nasreen Abdul Aziz, Kenrick Ng, Prabhakar Rajan, Jonathan Shamash   +3 more
wiley   +1 more source

GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease. [PDF]

Cochrane Database Syst Rev
Aralica M, Nadarevic T, Colli A, Casazza G, Vranić L, Fraquelli M, Poropat G, Štimac D.   +7 more
europepmc   +1 more source

Giant Mediastinal Teratoma in a Child: A Case Report With a Brief Review of the Literature

Clinical Case Reports, Volume 14, Issue 5, May 2026.
Contrast‐enhanced axial chest CT showing a large, well‐circumscribed mediastinal mass measuring approximately 15.9 × 14.1 cm (maximum axial dimensions). The lesion is predominantly of fluid attenuation, occupies nearly the entire left hemithorax, and produces marked rightward deviation of the mediastinum, compression of the contralateral lung ...
Urías Hernandez Lopez, Pastor Thomas Olivares, Alex Fernández Arrieta, Juan Correa Palacio, Aura Guevara Díaz, Ana Guerra Urquijo   +5 more
wiley   +1 more source

Development and Validation of a Lectin-independent Liquid Chromatography-Tandem Mass Spectrometry Method for Serum Glycosylated Alpha-fetoprotein Analysis and Comparison with a Liquid-phase Binding Assay. [PDF]

Ann Lab Med
Kim H, Park J, Suh H, Lee S, Park Y, Yang WS, Minn D, Kim SS, Cheong JY, Baek JH.   +9 more
europepmc   +1 more source

Genetic Characterization and Multidisciplinary Management of Complete Androgen Insensitivity Syndrome: Unveiling a Novel AR Mutation

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A novel AR frameshift mutation (c.2023_2035del) was identified in a 17‐year‐old phenotypic female with Complete Androgen Insensitivity Syndrome (CAIS). This report emphasizes the necessity of molecular characterization and multidisciplinary management to address diagnosis, surgical timing, and psychological well‐being in disorder of sex ...
Astorino Maria Francesca, Scalise Serena, Di Bella Chiara, La Rosa Maria Angela, Piraino Basilia, Calabrò Marco, Gentile Mattia, Ruggeri Rosaria Maddalena, Esposito Emanuela, Briuglia Silvana, Cannavò Salvatore   +10 more
wiley   +1 more source

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels. [PDF]

J Chin Med Assoc
Huang KJ, Ho CT, Lee PC, Chen SC, Liu CA, Chou SC, Lee IC, Huang YH, Luo JC, Hou MC, Wu JC, Su CW.   +11 more
europepmc   +1 more source

Alpha Fetoprotein and Hepatic Regeneration

Gastroenterology, 1979
M F, Chen, Y F, Liaw, M F, Chen
openaire   +2 more sources

Pathological Complete Response in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Following Conversion Therapy With TACE, HAIC, Lenvatinib, and Sintilimab: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) is an advanced disease with poor prognosis and limited treatment options. Conversion therapy integrating locoregional and systemic modalities may expand surgical eligibility, but achieving pathological complete response (pCR) remains rare.
Weidong Zhang, Huihui Shen, Xinglong Wang, Jingjing Gu, Minghai Shen, Qinghua Zhang   +5 more
wiley   +1 more source

Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study

Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Neoadjuvant disitamab vedotin combined with camrelizumab and S‐1 achieved high pathological response rates with manageable safety in resectable HER2‐overexpressing gastric and gastroesophageal junction cancer. Longitudinal circulating tumour DNA methylation profiling enabled dynamic monitoring of molecular response during treatment.
Longgang Wang, Bing Liu, Luguang Liu, Liqing Liu, Rong Li, Shumei Han, Xu Sun, Bo Bi, Yuanlin Sun, Dong Sun, Jie Chai   +10 more
wiley   +1 more source

[Alpha fetoprotein].

Ginekologia polska, 1979
openaire   +3 more sources